Immunoprecise’s COVID-19 Antibody Cocktail Shows Favorable Safety, Toxicity Profile
Immunoprecise Antibodies Ltd (NASDAQ: IPA) has reported preclinical data of PolyTope TATX-03 antibody cocktail therapy against COVID-19.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 95 companies set new 52-week lows.
Immunoprecise Antibodies Reports Its Talem Therapeutics Subsidiary Entered Multi-Year, Multi-Target Research Collab With Pierre Fabre With Goal To Discover, Develop Therapeutics
IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ:IPA) (TSXV:IPA) and the Pierre Fabre pharmaceutical group announced today that IPA’s subsidiary, Talem Therapeutics LLC
Earnings Scheduled For September 9, 2021
Companies Reporting Before The Bell
• Li-Cycle Holdings (NYSE:LICY) is likely to report earnings for its third quarter.
Analyzing ImmunoPrecise Antibodies’s Unusual Options Activity
On Monday, shares of ImmunoPrecise Antibodies (NASDAQ:IPA) saw unusual options activity. After the option alert, the stock price moved up to $8.27.
Unusual Options Activity Insight: ImmunoPrecise Antibodies
Shares of ImmunoPrecise Antibodies (NASDAQ:IPA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $6.93.